Keryx Biopharma (KERX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents
Short-term investment securities
Interest receivable
Other current assets	3.47M
Total current assets	159.95M
Property, plant and equipment, net	4.44M
Goodwill	3.21M
Other assets, net	1.02M
Total assets	168.63M
Accounts payable and accrued expenses	13.12M
Accrued compensation and related liabilities	4.92M
Deferred revenue	0
Total current liabilities	18.28M
Contingent equity rights
Other liabilities	1.18M
Total liabilities	146.64M
Preferred stock, $0.001 par value per share (5,000,000 shares authorized, no shares issued and outstanding)	0
Common stock, $0.001 par value per share (95,000,000 shares authorized, 69,771,035 and 61,521,483 shares issued, 69,691,087 and 61,441,535 shares outstanding at June 30, 2011 and December 31, 2010, respectively)	106K
Additional paid-in capital	823.55M
Treasury stock, at cost, 79,948 shares at June 30, 2011 and December 31, 2010, respectively	-357K
Accumulated deficit	-801.31M
Total stockholders' equity	21.99M
Total liabilities and stockholders' equity	168.63M

Entities mentioned with KERX

View All Entities